X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home IPR Data Management

Elevating Vaccine Stability Through Predicting mRNA Degrades

Content Team by Content Team
13th April 2023
in IPR Data Management, News

Messenger ribonucleic acid (mRNA) as a therapeutic method is gaining traction due to its ease of production and promising results.

mRNA-based vaccines, for example, have been critical in the fight against COVID-19 in many parts of the world. Yet, because of their thermal instability, mRNA-based therapies can be vulnerable to chemical destruction. As a result, mRNA vaccines require demanding manufacturing, storage, and robust international distribution. Understanding and improving the stability of mRNA vaccines is crucial for making them more widely available.

Dr. Qing Sun, a professor in Texas A&M University’s Artie McFerrin Department of Chemical Engineering, and a group of graduate students created a successful and interpretable model using deep-learning methods that can predict RNA degradation more appropriately than previous best methods such as Degscore models, RNA folding algorithms, as well as other machine-learning models. Their model was put to the test, and the results were recently reported in briefings in bioinformatics.

According to Sun, the intrinsic temperature instability of mRNA has restricted the global distribution of mRNA vaccines due to in-line hydrolysis, a chemical degradation reaction. As a result, their research aims to comprehend and anticipate mRNA breakdown. To address this issue, Sun and her colleagues turned to deep-learning approaches, creating the RNAdegformer, a deep-learning-based model supported by artificial neural networks that have the ability to gather data and apply this knowledge to create predictions.

Sun claims that the RNAdegformer analyses RNA sequences with self-attention and repetitions, two deep-learning approaches that have proven dominant in the realms of computer vision and natural language processing, while exploiting the biophysical properties of RNA secondary structure features and base pairing probabilities.

She further added that the RNAdegformer exceeds prior best approaches at predicting degradation qualities at the nucleotide level, which are like sentences’ letters that combine to produce mRNA. Each nucleotide of the COVID-19 mRNA vaccine can be predicted. When compared to prior best methods, RNAdegformer predictions have a better connection with RNA’s in vitro half-life.

Furthermore, the study demonstrates how direct visualisation of self-attention maps aids in informed decision-making. According to Shujun He, the paper’s first author and a graduate student in Sun’s group, attention maps demonstrate how the model thinks using input information, which aids in making knowledgeable decisions based on model predictions. Furthermore, their model indicates critical characteristics in determining mRNA degradation rates.

Researchers partnered with Rhiju Das, an associate professor of biochemistry at Stanford University, whose high-quality mRNA degradation data served as the study’s starting point. With this research, they aim to be able to build more stable mRNA vaccines using their methodology, allowing for more equity and a broader use of mRNA therapies, Sun added.

Previous Post

Microbial Fermentation Tech Market To Go Beyond $56b In 2023

Next Post

Customised Blood Pressure Treatment Can Get More Protection

Related Posts

Clinical Trials

Bio-Rad to Acquire Stilla Technologies by Q3 2025

28th February 2025
News

Types of Pharmaceutical Waste and How to Dispose of Them

31st December 2024
Developing Pharma Skills With Life Sci For Growth Initiative
News

UK Medicine Manufacturing Regulatory Framework For Care

6th November 2024
News

Nanoemulsion Drug Delivery Enhances Tuberculosis Care

6th November 2024
News

The Future of Drug Delivery Systems In Modern Medicine

6th November 2024
Revolutionizing Drug Discovery With AI For A Greener Future
News

AI and Nanotech Innovations in Advancing Drug Discovery

5th November 2024
Next Post
Customised Blood Pressure Treatment Can Get More Protection

Customised Blood Pressure Treatment Can Get More Protection

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In